Inscripción
profesionales sanitarios
para pacientes y familiares
Today, we announced positive Phase 3 topline results for our investigational therapy in head and neck cancer. The findings reinforce the potential of our differentiated antibody science and reflect our continued commitment to developing transformative medicines for people living
#HNSCC #ESMO26
RADIAN-TTCC Dostarlimab and niraparib in the CRT soace in LA PD-L1+ disease
An stunning effort from Dr Oliva, rest investigators and the spanish cooperative group @ttccgroup
@myESMO @OncoAlert @brunolarvol
@FundacionTTCC
⚕️XVII Curso de Formación Conjunta en Tumores de Cabeza y Cuello. Inscripción Abierta. Sólo xa profesionales sanitarios. Aval Científico de #SECOMmxf et al, vía @FundacionTTCC
🍀https://cursoformacionconjunta.fundacionttcc.com/
🗓️De 15 Noviembre a 15 Diciembre 2026💻On-line
Today, we announced positive Phase 3 topline results for our investigational therapy in head and neck cancer. The findings reinforce the potential of our differentiated antibody science and reflect our continued commitment to developing transformative medicines for people living
#HNSCC #ESMO26
RADIAN-TTCC Dostarlimab and niraparib in the CRT soace in LA PD-L1+ disease
An stunning effort from Dr Oliva, rest investigators and the spanish cooperative group @ttccgroup
@myESMO @OncoAlert @brunolarvol
@FundacionTTCC
⚕️XVII Curso de Formación Conjunta en Tumores de Cabeza y Cuello. Inscripción Abierta. Sólo xa profesionales sanitarios. Aval Científico de #SECOMmxf et al, vía @FundacionTTCC
🍀https://cursoformacionconjunta.fundacionttcc.com/
🗓️De 15 Noviembre a 15 Diciembre 2026💻On-line
Today, we announced positive Phase 3 topline results for our investigational therapy in head and neck cancer. The findings reinforce the potential of our differentiated antibody science and reflect our continued commitment to developing transformative medicines for people living
#HNSCC #ESMO26
RADIAN-TTCC Dostarlimab and niraparib in the CRT soace in LA PD-L1+ disease
An stunning effort from Dr Oliva, rest investigators and the spanish cooperative group @ttccgroup
@myESMO @OncoAlert @brunolarvol
@FundacionTTCC
⚕️XVII Curso de Formación Conjunta en Tumores de Cabeza y Cuello. Inscripción Abierta. Sólo xa profesionales sanitarios. Aval Científico de #SECOMmxf et al, vía @FundacionTTCC
🍀https://cursoformacionconjunta.fundacionttcc.com/
🗓️De 15 Noviembre a 15 Diciembre 2026💻On-line
TTCC en cifras
